Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
Abstract Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti‐cancer agents for treatment of Gastric cancers.
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/65674c3e054d4917ac8f5a42efa27c35 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:65674c3e054d4917ac8f5a42efa27c35 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:65674c3e054d4917ac8f5a42efa27c352021-12-01T06:36:07ZResponse to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma2050-090410.1002/ccr3.4986https://doaj.org/article/65674c3e054d4917ac8f5a42efa27c352021-11-01T00:00:00Zhttps://doi.org/10.1002/ccr3.4986https://doaj.org/toc/2050-0904Abstract Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti‐cancer agents for treatment of Gastric cancers.Sewanti LimayeDarshana PatilDadasaheb AkolkarNavin SrivastavaRevati PatilSachin ApurwaSanket PatilJinumary JohnRahul GosaviPrabhu NesargikarPrashant KumarVineet DattaChirantan BoseZarrine RaaziAjay SrinivasanRajan DatarWileyarticlecombination regimenencyclopedic tumor analysisgastric adenocarcinomapazopanibpersonalized cancer treatmentprecision oncologyMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
combination regimen encyclopedic tumor analysis gastric adenocarcinoma pazopanib personalized cancer treatment precision oncology Medicine R Medicine (General) R5-920 |
| spellingShingle |
combination regimen encyclopedic tumor analysis gastric adenocarcinoma pazopanib personalized cancer treatment precision oncology Medicine R Medicine (General) R5-920 Sewanti Limaye Darshana Patil Dadasaheb Akolkar Navin Srivastava Revati Patil Sachin Apurwa Sanket Patil Jinumary John Rahul Gosavi Prabhu Nesargikar Prashant Kumar Vineet Datta Chirantan Bose Zarrine Raazi Ajay Srinivasan Rajan Datar Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma |
| description |
Abstract Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti‐cancer agents for treatment of Gastric cancers. |
| format |
article |
| author |
Sewanti Limaye Darshana Patil Dadasaheb Akolkar Navin Srivastava Revati Patil Sachin Apurwa Sanket Patil Jinumary John Rahul Gosavi Prabhu Nesargikar Prashant Kumar Vineet Datta Chirantan Bose Zarrine Raazi Ajay Srinivasan Rajan Datar |
| author_facet |
Sewanti Limaye Darshana Patil Dadasaheb Akolkar Navin Srivastava Revati Patil Sachin Apurwa Sanket Patil Jinumary John Rahul Gosavi Prabhu Nesargikar Prashant Kumar Vineet Datta Chirantan Bose Zarrine Raazi Ajay Srinivasan Rajan Datar |
| author_sort |
Sewanti Limaye |
| title |
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma |
| title_short |
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma |
| title_full |
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma |
| title_fullStr |
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma |
| title_full_unstemmed |
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma |
| title_sort |
response to pazopanib‐based combination regimen in a case of fgfr3 amplified gastric adenocarcinoma |
| publisher |
Wiley |
| publishDate |
2021 |
| url |
https://doaj.org/article/65674c3e054d4917ac8f5a42efa27c35 |
| work_keys_str_mv |
AT sewantilimaye responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT darshanapatil responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT dadasahebakolkar responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT navinsrivastava responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT revatipatil responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT sachinapurwa responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT sanketpatil responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT jinumaryjohn responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT rahulgosavi responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT prabhunesargikar responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT prashantkumar responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT vineetdatta responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT chirantanbose responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT zarrineraazi responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT ajaysrinivasan responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma AT rajandatar responsetopazopanibbasedcombinationregimeninacaseoffgfr3amplifiedgastricadenocarcinoma |
| _version_ |
1718405478879330304 |